CD86 and ganglioneuroma: Statistically significant differences were observed between patients with GN and HV in the percentage of CTLA-4+ cells among CD4+ T cells and NK cells, as well as CD86+ cells in all analyzed subpopulations (Supplementary Materials, Figure S1G–J).